Analysis of Proposed New Standards for Nursing Homes Participating in Medicare and Medicaid
HRD-81-50: Published: Feb 20, 1981. Publicly Released: Feb 24, 1981.
Additional Materials:
- Full Report:
Contact:
GAO analyzed the impact of changes in nursing home quality of care standards included in a regulation proposed by the Department of Health and Human Services (HHS). This regulation applies to nursing homes which participate in Medicare and Medicaid programs. The two types of nursing homes which are affected by these changes are: (1) skilled nursing facilities, which provide covered care to Medicare and Medicaid patients; and (2) intermediate care facilities, which provide a slightly lower level of care and participate only in the Medicaid program administered by the States. Intermediate care facilities for the mentally retarded are not affected by the proposed changes.
The objectives of the new regulations include the elevation of patients' rights, the introduction of a patient care management system aimed at the care of the whole person, and the upgrading of the qualifications of key supervisors employed by the facilities. The new regulations should establish requirements for supervision of physician extenders and clearly state which functions are the patients' responsibility in respect to self-administration of medication. An industry estimate of the costs of compliance with the new regulations for facilities are approximately seven times the costs of compliance estimated by HHS. GAO was unable to determine which estimate was more realistic. Nursing home compliance with existing standards and individual requirements comprising these standards has been spotty. Many facilities are not complying with requirements which will be the key components of the proposed patient care management system. GAO has reservations about whether the regulations upgrading the quality of supervisory employees will have the desired impact in reducing noncompliance. There is a need for adequate oversight and enforcement of the regulations at Federal and State levels.
Recommendations for Executive Action
Status:
Comments: Please call 202/512-6100 for additional information.
Recommendation: The Secretary of HHS should direct the Administrator of Health Care Financing Administration (HCFA) to distribute guidelines and training aids free of charge to all participating facilities.
Agency Affected: Department of Health and Human Services
Status:
Comments: Please call 202/512-6100 for additional information.
Recommendation: The Secretary of HHS should direct the Administrator of HCFA to require the States to give the Department information on existing State requirements that are comparable to the proposed HHS new requirements.
Agency Affected: Department of Health and Human Services
Status:
Comments: Please call 202/512-6100 for additional information.
Recommendation: The Secretary of HHS should direct the Administrator of HCFA to modify the proposed conditions of participation to clearly define medication self-administration, including those pharmaceutical services standards for which the patients are accepting responsibility.
Agency Affected: Department of Health and Human Services
Status:
Comments: Please call 202/512-6100 for additional information.
Recommendation: The Secretary of HHS should direct the Administrator of HCFA to continue requiring State agencies to determine and report on compliance with individual requirements within a standard, should the Department elect not to cite facilities for noncompliance with requirements below the standard level.
Agency Affected: Department of Health and Human Services
Status:
Comments: Please call 202/512-6100 for additional information.
Recommendation: The Secretary of HHS should direct the Administrator of HCFA to establish uniform requirements for supervision of physican extenders under the Rural Health Clinic Services and long-term care programs.
Agency Affected: Department of Health and Human Services
Explore the full database of GAO's Open Recommendations
»
Mar 1, 2021
-
Medicare Part B:
Payments and Use for Selected New, High-Cost DrugsGAO-21-252: Published: Mar 1, 2021. Publicly Released: Mar 1, 2021.
Feb 24, 2021
-
Covid-19:
Key Insights from GAO's Oversight of the Federal Public Health ResponseGAO-21-396T: Published: Feb 24, 2021. Publicly Released: Feb 24, 2021.
Feb 17, 2021
Feb 11, 2021
-
Operation Warp Speed:
Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing ChallengesGAO-21-319: Published: Feb 11, 2021. Publicly Released: Feb 11, 2021.
Feb 5, 2021
-
DOD Health Care:
DOD Should Monitor Implementation of Its Clinical Practice GuidelinesGAO-21-237: Published: Feb 5, 2021. Publicly Released: Feb 5, 2021. -
Medicaid:
CMS Needs to Implement Risk-Based Oversight of Puerto Rico's Procurement ProcessGAO-21-229: Published: Feb 5, 2021. Publicly Released: Feb 5, 2021. -
VA Health Care:
Community Living Centers Were Commonly Cited for Infection Control Deficiencies Prior to the COVID-19 PandemicGAO-21-195R: Published: Jan 6, 2021. Publicly Released: Feb 5, 2021.
Jan 28, 2021
-
COVID-19:
Critical Vaccine Distribution, Supply Chain, Program Integrity, and Other Challenges Require Focused Federal AttentionGAO-21-265: Published: Jan 28, 2021. Publicly Released: Jan 28, 2021.
Jan 21, 2021
-
Rural Hospital Closures:
Affected Residents Had Reduced Access to Health Care ServicesGAO-21-93: Published: Dec 22, 2020. Publicly Released: Jan 21, 2021. -
Health Care Funding:
Federal Obligations to and Funds Received by Certain Organizations Involved in Health-Related Services, 2016 through 2018GAO-21-188R: Published: Dec 21, 2020. Publicly Released: Jan 21, 2021.
Looking for more? Browse all our products here